Cross-Sector entity
United Imaging Intelligence is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. pharma accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 2 original sources each.
2 verified stories tracked
Last mentioned: Mar 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
United Imaging Intelligence is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. pharma accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. The tracked stories average 2 original sources each. ECR 2026 appears in 2 tracked Cross-Sector stories from March 12, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering ECR 2026. Shared-story counts are live from our verified record — not editorial picks.
ECR 2026 Presentation
United Imaging Intelligence unveils its 'AI at Scale' strategy in Vienna.
European Market Push
Expected increase in partnerships with European hospital networks following ECR showcase.
Portfolio Expansion
UII expands uAI platform to include advanced neuro and oncology suites.
United Imaging Intelligence (UII) showcased its latest medical AI advancements at the European Congress of Radiology (ECR) 2026, focusing on clinical validation and large-scale deployment. The company's strategy emphasizes integrating AI across multiple imaging modalities to streamline diagnostic workflows and improve patient outcomes.
United Imaging Intelligence (UII) showcased its latest AI-driven radiology solutions at the European Congress of Radiology (ECR) 2026, focusing on clinical validation and scalable deployment. The company's presentation highlighted a shift from experimental AI to integrated, full-stack clinical workflows.
